Studies from Guangdong Pharmaceutical University in the Area of Non-Small Cell Lung Cancer Reported (Functional Characterization and Development of Novel Human Kinase Insert Domain Receptor Chimeric Antigen Receptor T-cells for Immunotherapy of ...)

Press/Media

Period13 Jan 2023

Media coverage

1

Media coverage

  • TitleStudies from Guangdong Pharmaceutical University in the Area of Non-Small Cell Lung Cancer Reported (Functional Characterization and Development of Novel Human Kinase Insert Domain Receptor Chimeric Antigen Receptor T-cells for Immunotherapy of ...)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date13/01/23
    PersonsMichael Hamblin